ClinConnect ClinConnect Logo
Search / Trial NCT06896929

Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies

Launched by CHILDREN HOSPITAL AND INSTITUTE OF CHILD HEALTH, LAHORE · Mar 25, 2025

Trial Information

Current as of April 22, 2025

Not yet recruiting

Keywords

Comparison Of Permethrin And Ivermectin In Scabies

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 6-15
  • Both genders
  • Diagnosed with scabies (as per operational definition)
  • Exclusion Criteria:
  • Children with recurrent scabies on medical record
  • Known allergy to ivermectin or permethrin.
  • Widespread eczema or impetigo.
  • Liver dysfunction or renal failure

About Children Hospital And Institute Of Child Health, Lahore

The Children Hospital and Institute of Child Health in Lahore is a premier pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and high-quality medical care. As a leading sponsor of clinical trials, the institute emphasizes the importance of evidence-based practices and strives to enhance treatment options for various pediatric conditions. With a commitment to ethical standards and patient safety, the hospital collaborates with healthcare professionals, researchers, and academic institutions to foster groundbreaking studies that aim to improve pediatric outcomes and contribute to global health knowledge.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported